2237 Phospho-EGF Receptor (Tyr1045) Antibody #2237

"上海博耀生物销售Phospho-EGF Receptor (Tyr1045) Antibody #2237，CST原装品质，价格优惠，订购Phospho-EGF Receptor (Tyr1045

"上海博耀生物销售Phospho-EGF Receptor (Tyr1045) Antibody #2237，CST原装品质，价格优惠，订购Phospho-EGF Receptor (Tyr1045) Antibody #2237，详情请咨询销售人员！
产品详细参数如下>>>>

产品名称：Phospho-EGF Receptor (Tyr1045) Antibody #2237
货号：2237
品牌：CST(cell signaling)
抗体来源：Rabbit
克隆类型： Polyclonal
规格：

No.	Size	Price
2237P	40 ul (4 western blots)	询价
2237S	100 ul (10 western blots)	询价

抗体应用：

Applications	Reactivity	Sensitivity	MW (kDa)	Source
W IF-IC	H R	Endogenous	175	Rabbit

Applications Key:  W=Western Blotting  IHC-P=Immunohistochemistry (Paraffin)  IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:  H=Human  R=Rat
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on sequence homology.
特异性/敏感度： Phospho-EGF Receptor (Tyr1045) Antibody detects EGF receptor only when phosphorylated at tyrosine1045. The antibody may cross-react with other activated EGF receptor family members (e.g. ErbB2).
来源及纯化方法： Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Tyr1045 of human EGF receptor. Antibodies are purified by protein A and peptide affinity chromatography.
抗体背景：

The epidermal growth factor (EGF) receptor is a transmembrane tyrosine kinase that belongs to the HER/ErbB protein family. Ligand binding results in receptor dimerization, autophosphorylation, activation of downstream signaling, internalization, and lysosomal degradation (1,2). Phosphorylation of EGF receptor (EGFR) at Tyr845 in the kinase domain is implicated in stabilizing the activation loop, maintaining the active state enzyme, and providing a binding surface for substrate proteins (3,4). c-Src is involved in phosphorylation of EGFR at Tyr845 (5). The SH2 domain of PLCγ binds at phospho-Tyr992, resulting in activation of PLCγ-mediated downstream signaling (6). Phosphorylation of EGFR at Tyr1045 creates a major docking site for the adaptor protein c-Cbl, leading to receptor ubiquitination and degradation following EGFR activation (7,8). The GRB2 adaptor protein binds activated EGFR at phospho-Tyr1068 (9). A pair of phosphorylated EGFR residues (Tyr1148 and Tyr1173) provide a docking site for the Shc scaffold protein, with both sites involved in MAP kinase signaling activation (2). Phosphorylation of EGFR at specific serine and threonine residues attenuates EGFR kinase activity. EGFR carboxy-terminal residues Ser1046 and Ser1047 are phosphorylated by CaM kinase II; mutation of either of these serines results in upregulated EGFR tyrosine autophosphorylation (10).

关键词：CST，抗体，一抗{byao_back}{byao_back2}

相关产品：
Anti-PCDH11Y原钙粘附蛋白11Y抗体
Anti-kappa Opioid receptorkappa型阿片受体抗体
Anti-CHRNA4烟碱型乙酰胆碱受体α4抗体
Anti-c-fosc-fos抗体
ab103142/Anti-CPSF30 antibody
ab103347/Anti-FARS2 antibody
ab10354/Anti-ASIC3 antibody
ab100927/Anti-DUSP22 antibody
ab102041/Anti-C1orf144 antibody
ab103623/Anti-GRB7 antibody
Anti-ASTN2星形肌动蛋白抗体
Anti-LRRK2富亮氨酸重复激酶2抗体
Anti-Selenoprotein W硒蛋白W抗体
ab102060/Anti-CD299 antibody
Anti-Caspase-12半胱胺酸蛋白酶蛋白-12抗体
ab10414/Anti-EGFR antibody"
本页产品地址：http://www.geilan.com/sell/show-3242304.html